Roche recently announced that it received the CE mark for its new self-administered COVID-19 antigen test, which will be available in countries accepting the CE mark by the middle of this...
HHS recently issued a fifth amendment to the Declaration under the Public Readiness and Emergency Preparedness Act (PREP Act) to add categories of qualified persons authorized to prescribe,...
GSK and Novartis recently announced a research collaboration to uncover potential links between genetic diversity across regions in Africa and drug response and ultimately drug development.
The...
President Joe Biden recently signed an executive order to accelerate the development of novel COVID-19 therapies and improve access to care for all Americans.
First, Biden called on the HHS and...
Thermo Fisher Scientific recently announced that it entered into a $450 million definitive agreement to acquire San Diego-based Mesa Biotech, Inc. and boost the availability of reliable molecular...
The US will remain a member of the World Health Organization (WHO) under President Joe Biden and will join COVAX, a global COVID-19 vaccine program led by WHO, NIAID Director Anthony Fauci, MD, said in...
President Joe Biden recently signed an executive order to combat COVID-19 and prepare for future biological and pandemic threats.
“The Federal Government must act swiftly and aggressively...
HHS recently announced that it will expand access to medication-assisted treatment (MAT) for opioid use disorder.
Under the agency’s guidelines, Practice Guidelines for the Administration for...
Vir Biotechnology and GSK recently announced an agreement with UK-based AGILE initiative to evaluate the company’s COVID-19 antibody, VIR-7832, in a Phase 1b/2a clinical trial.
The AGILE trial...
HHS recently announced that it will provide more than $22 billion in funding to states, localities, and territories to support COVID-19 testing and vaccination.
Over $19 billion of the funding,...
Kite, a Gilead Company, and Oxford BioTherapeutics recently entered into a collaboration to research and evaluate five novel cell therapies for hematologic and solid tumor indications.
Oxford...
FDA recently issued an emergency use authorization (EUA) for Abbott’s COVID-19 antigen test, the BinaxNOW COVID-19 Ag Card Home Test, for use by patients with a prescription.
The test is...
Cerner recently announced that an investment in Elligo Health Research will increase access to clinical trials by offering clinical trial resourcesin the Cerner Learning Health...
Bayer recently announced the launch of a cell and gene therapy platform (C>) within its pharmaceutical division.
The platform will further consolidate its emerging leadership in the cell and...
HHS recently announced that all tribal health programs and Urban Indian Organizations (UIOs) have chosen their preferred method for receiving a COVID-19 vaccine.
Tribal health programs and UIOs have...
FDA recently authorized the first at-home influenza and COVID-19 diagnostic test intended for patients who are suspected of respiratory viral infection consistent with the coronavirus.
The test,...
Roche recently announced that its COVID-19 antibody test, Elecsys, received FDA emergency use authorization.
Elecsys Anti-SARS-CoV-2 S measures the level of antibodies to the spike protein of...
HHS and the Department of Defense (DoD) recently awarded an $11.6 million contract to Puritan Medical Products Company, LLC to boost domestic production of nasal swabs used for COVID-19 tests.
The...
The Pharmaceutical Research Manufacturers of America (PhRMA) recently announced the release of industry-wide principles on clinical trial diversity.
The principles focus on four areas, including...
Amazon is moving into the pharmacy business by launching its own online pharmacy and prescription delivery services, the company recently announced.
The first offering, Amazon Pharmacy, allows...
